FOXM1 and ovarian neoplasm: Meta-analyses of FOXM1 in human solid tumors reported that FOXM1 protein expression in ovarian tumors coincides with an overall hazard ratio (HR) of 1.34 (95% CI = 0.96–1.88) for overall survival [323] and an odds ratio (OR) of 2.34 (95% CI = 1.30–4.20) for 3-year overall survival [324].